Publication, Part of NICE Technology Appraisals in the NHS in England (Innovation Scorecard)
NICE Technology Appraisals in the NHS in England (Innovation Scorecard), To June 2023
Official statistics
Summary
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE).
NHS England has produced and published the Innovation Scorecard as an Official Statistic since January 2013 on behalf of the Office for Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.
NHS England are working with the NHS BSA for the transfer of this publication series to the NHS BSA from April 2024.
The scorecard is produced using a range of administrative data sources prior to publication and no additional central data collection is involved.
In 2021, the publication series switched to use the Secondary Care Medicines data that is supplied by Rx-Info and now published by the NHS BSA through their open data portal to provide a richer source of data down to hospital Trust level. This data is not directly comparable with the secondary care data used in previous publications due to variations in the coverage and completeness and changes in some of the prescribing measures used to present volume of use in this publication.
NEW: This publication includes an additional 4 medicine groupings (COVID-19, icosapent ethyl, obesity and hATTR polyneuropathy), 1 replacement grouping (SGLT-2 inhibitors replacing the Diabetes grouping) and 2 updates to existing groupings (multiple sclerosis and migraine).
NEW: This publication includes 2 new (multiple sclerosis and icosapent ethyl) and 1 substantially revised (migraine) estimated expected uptake figures for medicine groupings, which are shown in the national level groupings dashboard.
NEW: A chapter is included describing the methodology for assigning Assumed Daily Doses (ADDs) at medicine presentation level.
NEW: The csv files within the zip archives in the Resources section include an additional variable containing ONS statistical geography codes to facilitate linking to map boundary files.
Highlights
Medicines
180 medicines reported on, 76.9% of 160 medicines prescribed more *
Medicine Groupings
17 medicine groupings, 15 were used more *
* those medicines with data for each of the latest 8 quarters comparing the 12 months from July 2022 to June 2023 to the previous 12 months. Year on year comparisons of the volume of medicine use may have been impacted by the effects of COVID.
Reported as Assumed Daily Doses (ADD), Defined Daily Doses (DDD), mgs, vials, tablets, units, or implants per 100,000 population in England
Source: NHS England
Key Facts
Administrative Sources
• English Prescribing Dataset (EPD) published by the NHS Business Services Authority • Secondary Care Medicines Data (SCMD) published by the NHS Business Services Authority • Hospital Episode Statistics (HES) data from NHS England • Population data from Office for National Statistics
Resources
Last edited: 27 October 2023 4:46 pm